HERAMED LIMITED — Capital/Financing Update 2020

Aug 4, 2020

5 August 2020

==> picture [85 x 45] intentionally omitted <==

5 August 2020

Dear Sir/Madam

NOTIFICATION PURSUANT TO PARAGRAPH 708A(5)(e) OF THE CORPORATIONS ACT 2001

This notice is given by HeraMED Limited (ACN 626 295 314) (“ HMD ” or “ Company ”) (ASX:HMD) pursuant to section 708A(5)e of the Corporations Action 2001 (Cth) ( Corporations Act ).

On 10 August 2020, the Company will be issuing 922,213 fully paid ordinary shares to sophisticated investors of Henslow Pty Ltd at $0.09.

The Company hereby gives notice that:

• (a) The Shares are part of the class of ordinary shares quoted on the ASX;

• (b) The Company will be issuing the Securities without disclosure to investors under Part 6D.2 of the Corporations Act, in reliance on section 708 and that notification is being given under Section 708A(5)(e) of the Act;

• (c) As at the date of this notice, the Company has complied with the provisions of Chapter 2M of the Act as they apply to the Company, and section 674 of the Act; and

• (d) As at the date of this notice, there is no information:

  • (i) that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

  • (ii) That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

    • A. the assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

    • B. the rights and liabilities attaching to the Shares.

Yours faithfully

Jonathan Hart

Company Secretary HeraMED Limited

HeraMED Limited ACN 626 295 314 T: +61 2 8379 2961 | A: Suite 3, Level 10, 23-25 Hunter Street SYDNEY NSW 2000